Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04452214
Title A Study of the Safety and Tolerance of CAN04 in Combination With Pembrolizumab in Subjects With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cantargia AB
Indications

transitional cell carcinoma

head and neck squamous cell carcinoma

melanoma

lung non-small cell carcinoma

Therapies

Nidanilimab + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Cancer Center Recruiting Aurora Colorado 80045 United States Details
Florida Cancer Specialists & Research Institute Recruiting Lake Mary Florida 32746 United States Details
Hospital of The University of Pennsylvania Recruiting Philadelphia Pennsylvania 19104-5127 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field